Diffuse Large B-Cell Lymphoma With Membranous Proliferative Glomerulonephritis as the First Manifestation: A Case Report. [PDF]
Xiao H, Ye L, Zhang F.
europepmc +1 more source
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan+12 more
wiley +1 more source
Coexistence of primary diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient with Hashimoto's thyroiditis: A case report. [PDF]
Hou T, Nie F.
europepmc +1 more source
Designing next‐generation immune cell therapies with nanomaterials
Nanomaterials are transforming immune cellular therapies (ICT) by addressing challenges like tumor accessibility and lengthy manufacturing. This perspective highlights innovations such as magnetic nanoparticles for target identification, lipid nanoparticles for T cell stimulation, and nanoparticle‐mediated gene cytokine delivery. These advances promise
Kangfu Chen, Wenhan Wang, Zongjie Wang
wiley +1 more source
CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting. [PDF]
Tomarchio V, Rigacci L, Annibali O.
europepmc +1 more source
Subcutaneous Panniculitis‐like T‐cell Lymphoma
Arthritis &Rheumatology, Accepted Article.
Shae Chambers+2 more
wiley +1 more source
A novel cancer-associated fibroblast-related gene signature for predicting diffuse large B cell lymphoma prognosis using weighted gene co-expression network analysis and machine learning. [PDF]
Cui H, Chen M, Zhao M, Li B.
europepmc +1 more source
Detection of Hematological Malignancies Using N-NOSE (Nematode-NOSE). [PDF]
Nakamura S+6 more
europepmc +1 more source
The transition between M1 and M2 macrophage phenotypes is associated with the disease status following CD19 CAR-T therapy for B cell lymphoma/leukemia. [PDF]
Zhao L+8 more
europepmc +1 more source